REQUEST A DEMO
Total
USD $0.00
Search more companies

Inrilab S.A. (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Inrilab S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Inrilab S.A. is based in Ecuador. The head office is in Guayaquil. It operates in the Medical and Diagnostic Laboratories sector. The company was established on June 30, 2010. Inrilab S.A. currently employs 10 (2023) people. The latest financial highlights indicate a net sales revenue increase of 840.88% in 2023. Its’ total assets recorded a growth of 19.86%. The net profit margin of Inrilab S.A. decreased by 25.77% in 2023.

Headquarters
Av. Ernesto Alban 33, (diagonal a Deprati Sur) Bldg.
Guayaquil; Guayas;

Contact Details: Purchase the Inrilab S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Inrilab S.A. report to view the information.
Outstanding Shares:
Purchase the Inrilab S.A. report to view the information.
Registered Capital:
Purchase the Inrilab S.A. report to view the information.
Incorporation Date:
June 30, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Inrilab S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
840.88%
Total operating revenue
840.88%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-35.68%
Total assets
19.86%
Total equity
33.39%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-25.77%
Return on Equity (ROE)
-26.89%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?